No Data
No Data
Express News | Entrada Therapeutics Promotes Natarajan Sethuraman, Phd, to President of Research and Development
Press Release: Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development
Āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to Its Board of Directors
Express News | Oppenheimer Reiterates Outperform on Entrada Therapeutics, Maintains $25 Price Target
Oppenheimer Initiates Entrada Therapeutics(TRDA.US) With Buy Rating, Announces Target Price $25
Entrada Therapeutics Insider Sold Shares Worth $440,801, According to a Recent SEC Filing